Results 201 to 210 of about 3,301,387 (267)

Self-propagating organelle biogenesis on synthetic beads

Peng M, Wong S, Xiao B, Blaya-Martinez L, Hu L, Feng Z, Mohamad N, Hasan M, Saurya S, Novak ZA, Monteiro JM, Harrison T, Chang C, Raff JW.   +13 more
europepmc   +1 more source

Primary adenoid cystic carcinoma of the breast: a clinicopathological case series. [PDF]

Korean J Clin Oncol
Kaur B, Govindarajan N, Sivaramalingam G, Radhakrishna S, Shankarraman D.   +4 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Endoscopic submucosal dissection: Challenges, innovations, and the road ahead. [PDF]

World J Gastrointest Endosc
Moutzoukis MK, Manolakis A, Kapsoritakis A, Christodoulou D, Argyriou K.   +4 more
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Pneumopericardium and multicompartmental air dissemination after colorectal endoscopic resection managed conservatively: a case report. [PDF]

Front Med (Lausanne)
Wu Z, Zhang J, Xu X, Li Z.
europepmc   +1 more source

Spatial biology in cancer epigenetics

Molecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

Electrical interface design for additively manufactured polymer anodes for biophotovoltaic systems. [PDF]

Front Microbiol
Anam M, Rivers G, Gomes RL, Wildman R, Gomes HI.   +4 more
europepmc   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Conventional Versus Underwater Endoscopic Mucosal Resection for Superficial Non-Ampullary Duodenal Epithelial Tumors ≤ 20 mm: Study Protocol for a Multicenter Randomized Controlled Trial (D-CURE Trial). [PDF]

Methods Protoc
Yoshida M, Hatta W, Nakamura T, Nakaya N, Shichijo S, Tanaka Y, Kanzaki H, Hirasawa K, Oda I, Hirose T, Kato M, Takizawa K, Toya Y, Hikichi T, Sawai H, Yoshida N, Dohi O, Masamune A, Abe S, Yano T, D-CURE Trial Group.   +20 more
europepmc   +1 more source